Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...respective of interval between the doses was 63.1%, based on a median follow-up of 80 days, but tended to be higher when this interval was longer. The data reviewed at this time support the conclusion that the known and potential benefits of ChAdOx1-S/nCoV-19 [recombinant] vaccine outweigh the known and potential risks.
more
PERC produces regional and member state situation analyses, updated regularly.
This policy brief explores the challenges faced in disaster risk governance in relation to the climate emergency.
Nota científica
24 de abril de 2020
El desarrollo de inmunidad a un patógeno por infección natural es un proceso de varias etapas que suele producirse a lo largo de una o dos semanas. El organismo responde a una infección vírica de forma inmediata a través de una respuesta innata no específ...ica, en la que los macrófagos, los neutrófilos y las células dendríticas frenan el avance del virus y pueden incluso evitar que este provoque síntomas. A esta respuesta no específica le sigue una respuesta adaptativa en la que el organismo genera anticuerpos que se unen específicamente al virus. Estos anticuerpos son las proteínas denominadas inmunoglobulinas. El organismo también genera linfocitos T que reconocen y eliminan las células infectadas por el virus: es lo que se conoce como inmunidad celular. Esta respuesta adaptativa combinada puede eliminar el virus del organismo y, si la respuesta es suficientemente intensa, puede evitar el agravamiento de la enfermedad o la reinfección por el mismo virus. Este proceso se mide a menudo a través de la presencia de anticuerpos en la sangre.
more
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...n two sections: the first section provides WHO insights on global vaccine market dynamics, drawing from data provided by Member States, which are, in turn, analysed and displayed in the second section.
more
I SURVIVED EBOLA:THANKS TO ASEOWA
Alimatou Camara Speaks of her battle with Ebola and of the Care she received at the ASEOWA run Ebola Treatment Unit in Guinea
Guinean Alimatou Camara, a seventeen year old housewife in a polygamous union, lost her mother in-law, her only daughter and her stepdau...ghter to Ebola. She got infected too, but survived, thanks to the African Union Support to Ebola Outbreak in West Africa (ASEOWA).
By Lilas Belepe,
Communication Officer, ASEOWA Guinee
A resident of Forécariah, a town situated one hundred kilometres away from Conakry, the capital of Guinea, she narrates the ordeal that befell her and her family, her battle with Ebola and the time she spent recovering at the African Union run Ebola Treatment Unit (ETU), in Coyah.
more
Being a caregiver can be an exhausting and difficult task. It’s important to recognize caregiver burnout and cope healthily. Understanding caregiver burnout symptoms and coping mechanisms can help make caregiving more enjoyable and fulfilling.About 1 in 3 adults serves as an informal caregiver to ...another adult, like an aging parent or disabled relative. Although many find the opportunity to care for a loved one to be a privilege, it can also be demanding. Here is how to cope effectively.
more
Diploma Program
For the Ethiopian Health Center Team
Part of the CBM Prevention Toolkit on Cerebral Palsy. | This manual is meant to be used in combination with the Flipcharts on Cerebral Palsy developed by CBM and CCBRT (Tanzania). The full Prevention Toolkit on Cerebral Palsy (composed of the A4 Flipcharts, this Manual and a Fact sheet) aims to miti...gate the disabling effects of cerebral palsy through improved new born care and greater community awareness.
more
UNFPA launches Journalist’s Handbook: Reporting on Gender-Based Violence in Syria Crisis
Amman, 9 March 2015 – Under the patronage of Her Royal Highness Princess Rym Ali, UNFPA launched a handbook on Reporting on Gender-Based Violence in the Syria Crisis to help journalists better understand ...issues surrounding gender-based violence (GBV) and to write about it more effectively and sensitively.
more
21 May 2021. he Practical Approach to Care Kit – PACK – is used by nurses, doctors and community health workers in their everyday work to care for patients at the clinic and in the community – PACK Adult, PACK Adolescent, PACK Child and PACK Community.
PACK Adult is also known as APC (Adult P...rimary Care) outside of the Western Cape. Both form part of the the Ideal Clinic initiative: www.idealhealthfacility.org.za
PACK Home is designed for people seeking more information about how to care for their own health and the health of their family at home.
Available in English, Afrikaans and isiXhosa
more
This topic last updated: Apr 28, 2020.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or condi...tions.
View in: English, Italian, French, German, Japanese, Brazilian Portuguese, Video in Spanish
more
WHO/CDS/CSR/EDC/99.2 Plague Manual
Epidemiology, Distribution, Surveillance and Control
Document d’information scientifique
24 avril 2020
Le développement d’une immunité face à un agent pathogène à la suite d’une infection naturelle comporte plusieurs étapes et prend généralement une à deux semaines. Une infection virale entraîne immédiatement une réponse immunit...aire innée, non spécifique, au cours de laquelle les macrophages, les neutrophiles et les cellules dendritiques ralentissent la progression du virus et peuvent même éviter l’apparition de symptômes. Cette réponse non spécifique est suivie d’une réponse adaptative, au cours de laquelle l’organisme produit des anticorps qui se lient spécifiquement au virus. Ces anticorps sont des protéines appelées immunoglobulines. L’organisme produit également des lymphocytes T qui reconnaissent et éliminent les cellules infectées par le virus. Cette réponse adaptative permet parfois d’éliminer le virus de l’organisme et, si elle est suffisamment forte, d’éviter l’aggravation de la maladie ou la réinfection par le même virus. Ce processus est souvent mesuré par la présence d’anticorps dans le sang.
more
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV).